"Low Dose" Metformin Improves Hyperglycemia Better Than Acarbose in Type 2 Diabetics

OBJECTIVES: "High dose" metformin therapy (2,550 mg/day) is reported to improve glycemic control in type 2 diabetic patients with obesity (body mass index (BMI) ≥ 30). Some have reported that metformin therapy, even in low doses (500-750 mg/day), improves glycemic control in non-obese type...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yajima, Ken, Shimada, Akira, Hirose, Hiroshi, Kasuga, Akira, Saruta, Takao
Format: Artigo
Idioma:Inglês
Publicat: SBDR - Society for Biomedical Diabetes Research 2004
Matèries:
Original Data
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1783540/
https://ncbi.nlm.nih.gov/pubmed/17491670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2004.1.89
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars